Structure and function of a new member of ectophosphodiesterase I

外切磷酸二酯酶I新成员的结构与功能

基本信息

  • 批准号:
    12670135
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

E-NPP (ecto-nucleotide pyrophosphatase/phosphodiesterase I) consists of three closely related molecules. E-NPP1 (PC-1) was first cloned as a plasma cell differentiating antigen. E-NPP-2 (autotaxin) was purified as an autocrine tumor cell motility stimulation factor from melanoma cells. And E-NPP3 was cloned from human prostate CDNA library. Forced overexpression of E-NPP3 gives fibroblasts and glioma cells an invasive property. We have investigated the expression and localization of E-NPP1 and 3 in human neoplastic bile duct diseases. Western blot analysis revealed that expression of E-NPP3 but not E-NPP1 was higher in tumor tissues than in surrounding tissues. Immunohistochemical analysis demonstrated that E-NPP1 was located at apical side of tumor cells while E-NPP3 was at the apical plasma membrane. Cleaved form of E-NPP3 protein but not E-NPP1 was readily detected in the cholangiocarcinoma patients' sera. In situ hybridization confirmed the presence of E-NPP1 and -3 mRNA in tumor tissues. Furthermore, NIH3T3 cells that stably transfected with E-NPP3 CDNA (NIH3T3/E-NPP3 cells) but not NIH3T3/E-NPP1 cells showed increased migration rate through collagen-coated membranes. These results suggest that E-NPP3 is involved in tumor cell infiltration of bile duct carcinoma and cholangiocarcinoma.
E-NPP(外核苷酸焦磷酸酶/磷酸二酯酶I)由三种密切相关的分子组成。E-NPP 1(PC-1)首先作为浆细胞分化抗原被克隆。E-NPP-2(autotaxin)是从黑素瘤细胞中纯化的自分泌肿瘤细胞运动刺激因子。从人前列腺cDNA文库中克隆了E-NPP 3。E-NPP 3的强制过表达赋予成纤维细胞和神经胶质瘤细胞侵袭性。我们研究了E-NPP 1和3在人胆管肿瘤性疾病中的表达和定位。Western blot分析显示,E-NPP 3在肿瘤组织中的表达高于癌旁组织,而E-NPP 1则无表达。免疫组化结果显示E-NPP 1定位于肿瘤细胞的顶侧,E-NPP 3定位于肿瘤细胞的顶侧质膜。胆管癌患者血清中易检测到E-NPP 3蛋白的裂解形式,而E-NPP 1蛋白则不存在。原位杂交证实肿瘤组织中存在E-NPP 1和-3 mRNA。此外,用E-NPP 3 cDNA稳定转染的NIH 3 T3细胞(NIH 3 T3/E-NPP 3细胞)而不是NIH 3 T3/E-NPP 1细胞显示出通过胶原包被的膜的迁移率增加。这些结果表明,E-NPP 3参与了胆管癌和胆管癌的肿瘤细胞浸润。

项目成果

期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sugahara K.: "Mice lacking CCAAT/enhancer-binding protein"Cell Tissue Res. 306. 57-63 (2001)
Sugahara K.:“缺乏 CCAAT/增强子结合蛋白的小鼠”细胞组织研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Rutsch, F., Vaingankar, S., Johnson, K.A., Goldfine, I., Maddux, B., Schauerte, P., Kalhoff, H., Sano, K., Boisvert, W.A., Superti-Furga, A., and Terkeitaub, R.: "PC-1 Nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arteria
Rutsch, F.、Vaingankar, S.、Johnson, K.A.、Goldfine, I.、Maddux, B.、Schauerte, P.、Kalhoff, H.、Sano, K.、Boisvert, W.A.、Superti-Furga, A.,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sano, K: "Structure of AF^3p^<21>"Leukemia Lymphoma. 42・4. 595-602 (2001)
Sano,K:“AF^3p^<21>的结构”白血病淋巴瘤42・4(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
KUmaki, S., Ishii, N., Minegishi, M., Ohashi, Y., Hakozaki, I., Nonoyama, S., Imai, K., Morio, T., Tsuge, I. Sakiyama, Y., Miyanoshita, A., Miura, J., Mayumi, M., Heike, T., Katamura, K., Takada, H., Izumi, I., Kamizono, J., Hibi, S., Sasaki, H., Kimura,
熊木 S.、石井 N.、峰岸 M.、大桥 Y.、箱崎 I.、野野山 S.、今井 K.、森尾 T.、柘植 I.、崎山 Y.、宫之下
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Biihring HJ.: "The basophil activation marker defined by antibody 97A6 is identical with the E-NPY3"Blood. 97・10. 3303-3305 (2001)
Biihring HJ.:“抗体 97A6 定义的嗜碱性粒细胞激活标记与 E-NPY3 相同”Blood.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SANO Kimihiko其他文献

SANO Kimihiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SANO Kimihiko', 18)}}的其他基金

Relationship between phosphodiesterase I activity and metastatic ability of cancer cells
磷酸二酯酶I活性与癌细胞转移能力的关系
  • 批准号:
    10670142
  • 财政年份:
    1998
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Application of a new tumor cell motility stimulating factor, PD-I family proteins todiagnosis and treatment of cancer.
新型肿瘤细胞运动刺激因子PD-1家族蛋白在癌症诊断和治疗中的应用。
  • 批准号:
    08670177
  • 财政年份:
    1996
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Enhancing T cell immunity to cancer metastasis
增强T细胞对癌症转移的免疫力
  • 批准号:
    MR/Y013301/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Research Grant
Investigating the Role of Drug Tolerant Persisters in Driving Colorectal Cancer Metastasis.
研究耐药性持续存在在驱动结直肠癌转移中的作用。
  • 批准号:
    491461
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Fellowship Programs
The Role of EpCAM Glycosylation in Breast Cancer Metastasis
EpCAM 糖基化在乳腺癌转移中的作用
  • 批准号:
    10605857
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Investigating mechanisms of bladder cancer metastasis
研究膀胱癌转移的机制
  • 批准号:
    10718278
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Intratumor heterogeneity in BRCA1-mutated breast cancer metastasis
BRCA1 突变乳腺癌转移的瘤内异质性
  • 批准号:
    10680318
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Illuminating the evolutionary history of colorectal cancer metastasis: basic principles and clinical applications
阐明结直肠癌转移的进化史:基本原理和临床应用
  • 批准号:
    10906574
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Analysis of the mechanism of pancreatic cancer metastasis targeting the kinetics of C4orf47 expression by reoxygenation
复氧作用下C4orf47表达动力学分析胰腺癌转移机制
  • 批准号:
    23K08132
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The metabolism of breast cancer metastasis to the lung: Key pathways and their implications in the metastatic microenvironment.
乳腺癌肺转移的代谢:关键途径及其在转移微环境中的影响。
  • 批准号:
    EP/Y029232/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Fellowship
"Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis"
“用于定量了解前列腺癌转移的基线和治疗驱动演变的新型小鼠模型”
  • 批准号:
    10660349
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Adaptations of breast cancer metastasis to the aging lung
乳腺癌转移对衰老肺部的适应
  • 批准号:
    10726328
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了